Persistent macular oedema following Best vitelliform macular dystrophy undergoing anti-VEGF treatment
TZ Lin, EE Pazo, Y Ren, LJ Shen
Abstract
Abstract not yet added. See the publisher page.
Access
How to cite
Lin, T., Pazo, E., Ren, Y., Shen, L. (2022). Persistent macular oedema following Best vitelliform macular dystrophy undergoing anti-VEGF treatment. International Journal of Ophthalmology. https://doi.org/10.18240/ijo.2022.05.22
@article{lin2022persistent,
title = {{Persistent macular oedema following Best vitelliform macular dystrophy undergoing anti-VEGF treatment}},
author = {Lin, TZ and Pazo, EE and Ren, Y and Shen, LJ},
journal = {International Journal of Ophthalmology},
year = {2022},
doi = {10.18240/ijo.2022.05.22},
url = {https://doi.org/10.18240/ijo.2022.05.22},
}
Related work
- Association between mean ocular perfusion pressure and proliferative diabetic retinopathy in a northern Chinese population (2026)
- Automated deep learning-based retinoschisis and detachment volume measurement in pathological myopia with posterior scleral contraction (2026)
- Development of a predictive model based on aqueous cytokines data for response to anti-VEGF therapy in diabetic macular edema (2026)
- Repeatability of cone photoreceptor metrics with a commercial adaptive optics scanning laser ophthalmoscopy (Mona II) in healthy adults (2026)
- Retinal and choroidal changes in diabetic patients before definitive diagnosis of diabetic retinopathy: a two-year prospective study (2026)